Chronologically different incidences of post-transplant malignancies in renal transplant recipients: Single center experience

Transplant International

Volumn 22, Issue 6, 2009, Pages 644-653

  Ju, Man Ki ^a   Joo, Dong Jin ^a   Kim, Soo Jin ^a   Huh, Kyu Ha ^a   Kim, Myoung Soo ^a   Jeon, Kyung Ock ^a   Kim, Hyun Jung ^a   Kim, Soon Il ^a   Kim, Yu Seun ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Immunosuppression; Kidney transplantation; Malignancy

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CHILD; COLORECTAL CANCER; FEMALE; HUMAN; KAPOSI SARCOMA; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; SCHOOL CHILD; SKIN CANCER; STOMACH CANCER; THYROID CANCER; URINARY TRACT CANCER; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; KIDNEY TRANSPLANTATION; KOREA; MALE; MIDDLE AGED; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; UROLOGIC NEOPLASMS;

EID: 65549122581     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2009.00846.x     Document Type: Article

References (37)

1. Stratta P, Morellini V, Musetti C, et al. Malignancy after kidney transplantation: results of 400 patients from a single center. Clin Transplant 2008 22 : 424.
2. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation 2005 15 : S254. (Pubitemid 41552912)
3. Andrés A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol 2005 56 : 71. (Pubitemid 41278647)
4. Kauffman HM, Cherikh WS, McBride MA, Cheng Y, Hanto DW. Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int 2006 19 : 607.
5. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004 4 : 905. (Pubitemid 38745589)
6. Available at: http://www.ctstransplant.org/ (last accessed on July 2008).
7. de Jong-Tieben LM, Berkhout RJ, ter Schegget J, et al. The prevalence of human papillomavirus DNA in benign keratotic skin lesions of renal transplant recipients with and without a history of skin cancer is equally high: a clinical study to assess risk factors for keratotic skin lesions and skin cancer. Transplantation 2000 69 : 44. (Pubitemid 30062606)
8. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999 354 : 20. (Pubitemid 29304297)
9. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA 2006 296 : 2823.
10. Imao T, Ichimaru N, Takahara S, et al. Risk factors for malignancy in Japanese renal transplant recipients. Cancer 2007 109 : 2109. (Pubitemid 46744207)
11. Hoshida Y, Aozasa K. Malignancies in organ transplant recipients. Pathol Int 2004 54 : 649. (Pubitemid 39297289)
12. Samhan M, Al-Mousawi M, Donia F, Fathi T, Nasim J, Nampoory MR. Malignancy in renal recipients. Transplant Proc 2005 37 : 3068. (Pubitemid 41435620)
13. Ministry of Health & Welfare, Republic of Korea. Cancer Incidence in Korea 1999-2001. Korea : Ministry of Health & Welfare, 2005 : 38 49 pp.
14. London NJ, Farmery SM, Will EJ, Davison AM, Lodge JP. Risk of neoplasia in renal transplant patients. Lancet 1995 346 : 403.
15. Birkeland SA, Løkkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000 355 : 1886. (Pubitemid 30311885)
16. TY Lee, HK Cho, KH Kim. A study of the completeness of Korean Cancer Registry. J Korean Soc Health Stat 2003 28 : 67.
17. Gutierrez-Dalmau A, Campistol JM. Immunosuppressive therapy and malignancy in organ transplant recipients: a systematic review. Drugs 2007 67 : 1167. (Pubitemid 46871026)
18. Selgrad M, Malfertheiner P, Fini L, Goel A, Boland CR, Ricciardiello L. The role of viral and bacterial pathogens in gastrointestinal cancer. J Cell Physiol 2008 216 : 378.
19. Persing DH, Prendergast FG. Infection, immunity, and cancer. Arch Pathol Lab Med 1999 123 : 1015. (Pubitemid 29526659)
20. Chapman J, Webster AC. Cancer Report: ANZDATA Registry 2004 Report : 99 pp. Available at: http://www.anzdata.org.au/ (last accessed on July 2008).
21. Port F. Standardized incidence ratio: the rate of de novo malignancies by site and transplanted organ compared to population-based controls. Paper presented at : Third Annual ASTS/Winter Symposium, Miami, FL, 2003.
22. Hoshida Y, Tsukuma H, Yasunaga Y, et al. Cancer risk after renal transplantation in Japan. Int J Cancer 1997 71 : 517. (Pubitemid 27239358)
23. Chen J, Cheong JH, Hyung WJ, et al. Gastric adenocarcinoma after renal transplantation. Hepatogastroenterology 2004 51 : 895. (Pubitemid 38590990)
24. Shroff R, Rees L. The post-transplant lymphoproliferative disorder - a literature review. Pediatr Nephrol 2004 19 : 369. (Pubitemid 38477398)
25. Cao S, Cox K, Esquivel CO, et al. Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation. Transplantation 1998 66 : 851. (Pubitemid 28487457)
26. Birkeland SA, Hamilton-Dutoit S. Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se? Transplantation 2003 76 : 984. (Pubitemid 37186032)
27. Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant 2007 22 (Suppl. 1 i4. (Pubitemid 47073738)
28. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001 3 : 70. (Pubitemid 32452921)
29. Agraharkar ML, Cinclair RD, Kuo YF, Daller JA, Shahinian VB. Risk of malignancy with long-term immunosuppression in renal transplant recipients. Kidney Int 2004 66 : 383. (Pubitemid 38870116)
30. Berger NA, Savvides P, Koroukian SM, et al. Cancer in the elderly. Trans Am Clin Climatol Assoc 2006 117 : 147.
31. Mihalov ML, Gattuso P, Abraham K, Holmes EW, Reddy V. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 1996 10 : 248. (Pubitemid 26257940)
32. Barrett WL, First MR, Aron BS, Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993 72 : 2186. (Pubitemid 23280145)
33. Dharnidharka VR, Sullivan EK, Stablein DM, Tejani AH, Harmon WE, North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 2001 71 : 1065. (Pubitemid 32448820)
34. Diehl V, Hauch P, Harris N. Hodgkin's disease. In : DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia, PA : Lippincott Williams & Wilkins, 2001 : 2339 pp.
35. Yarchoan R, Little RF. Immunosuppression-related malignancies. In : DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. Philadelphia, PA : Lippincott Williams & Wilkins, 2001 : 2575 pp.
36. Kauffman HM, Cherikh WS, Cheng Y, Hanto DW, Kahan BD. Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation 2005 80 : 883. (Pubitemid 41552882)
37. Campistol JM, Eris J, Oberbauer R, et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006 17 : 581.